Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021


HomeMicroPort Orthopedics Inc.MicroPort Orthopedics Optimizing its Episode of Care for Surgeons and Patients, Investing In New Technologies and Partnerships

MicroPort Orthopedics Optimizing its Episode of Care for Surgeons and Patients, Investing In New Technologies and Partnerships

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, is taking an Episode of Care approach to enhance operational efficiency and patient satisfaction throughout the 90 days both before and after surgery.

MicroPort is investing in new strategic technologies and partnerships with the vision to improve efficiencies, patient outcomes, and provider productivity.
Technologies built specifically around streamlining the Episode of Care ensure patients are prepared mentally and physically for their procedure and have digital resources to communicate with their doctors throughout the recovery process. Additionally, the resources can help healthcare providers monitor patients, predict risk, and manage outcomes.
To increase patient engagement and systematically measure patient outcomes, MicroPort recently partnered with PatientIQ, a platform that combines industry-leading patient engagement technology with research quality advanced analytics.
Together, PatientIQ and MicroPort Orthopedics are guiding the future of orthopedic care. With over 1,600 online education modules, PatientIQ provides a top-tier patient experience that can be specifically tailored to a procedure or a diagnosis. In addition to preoperatively educating and optimizing patients for their upcoming surgery, the platform also administers patient outcomes surveys and automates data collection throughout the entire Episode of Care to provide full service and support to both patients and surgeons.
MicroPort Orthopedics has also recently partnered with Dr. Aaron Salyapongse, orthopaedic surgeon in Dublin, California, to develop a Virtual Joint Class series moving patient education content to a digital format, allowing them to prepare for their upcoming surgery.
These classes, available through MicroPort’s proprietary PATHWAYS program, are specifically designed in a relatable and interactive blackboard style format to keep patients interested and engaged. They provide details about what to expect during and after the procedure. The classes not only introduce a breadth of topics including surgical preparation, anesthesia, discharge criteria, and post-op pain management, but also preemptively address many of the common causes for patient adverse events and readmissions.”
“Over the last 20 years, total joint replacement surgery has undergone a significant evolution. In the early 2000s, it was common for patients to spend days in a hospital for a procedure and then be moved to a skilled nursing facility for several weeks. Today, patients are routinely discharged hours after the procedure without any added risk and at a lower cost compared to a traditional inpatient setting,” said Benny Hagag, president of MicroPort Orthopedics.
Hagag concluded, “These systemic changes to the Episode of Care, combined with the impact of COVID-19 on today’s healthcare system, have required companies to adapt and prioritize innovation and technology at the center of care. Our recent collaboration and strategic partnerships with like-minded companies and surgeons are what keep us advancing toward positive patient outcomes and effective procedures, and we are only getting started.”
Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy